02.10.2012 - U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)